Key result
An enzyme-linked immunosorbent assay correctly identified Coxsackie B antigen in 19 of 21 tissue culture fluids and 5 of 9 rectal swab specimens, showing higher sensitivity than complement fixation.
The developed ELISA offers a highly sensitive method for the rapid identification of Coxsackie B antigens in clinical specimens and tissue cultures.
Answers are grounded in this paper and cite their sources.
May support sensitive Coxsackie B antigen detection in research; leaves open clinical validation in humans.
An enzyme-linked immunosorbent assay (ELISA) has been developed for the identification of Coxsackie B antigens. This assay was capable of identifying and distinguishing all six Coxsackie B serotypes at concentrations one hundredfold to ten thousandfold less than could be detected by complement fixation (CF) systems. In addition, the Coxsackie B ELISA correctly identified the presence of Coxsackie B antigen in 19 of 21 tissue culture fluids and five of nine rectal swab specimens. Two additional rectal swab specimens reacted with Coxsackie B antisera but could not be conclusively serotyped. Tissue culture fluids and rectal swab specimens containing other viruses such as ECHO virus, Coxsackie virus A, rhinovirus, rotavirus and Norwalk virus were consistently negative in the assay. The Coxsackie B ELISA offers potential for the rapid identification of Coxsackie B antigens in clinical specimens and tissue culture systems.
No takes yet. Share an insight, caveat, or question.
Yolken et al. (1980) studied Coxsackie B infection (n=30). Enzyme-linked immunosorbent assay (ELISA) vs. Complement fixation (CF) systems was evaluated on Detection and identification of Coxsackie B antigens. An enzyme-linked immunosorbent assay correctly identified Coxsackie B antigen in 19 of 21 tissue culture fluids and 5 of 9 rectal swab specimens, showing higher sensitivity than complement fixation.
Synapse has enriched 10 related papers. Consider them for comparative context: